Adaptive Biotechnologies Corporation · NASDAQ:ADPT

Rubinstein Julie sold 35,643 Adaptive Biotechnologies Corporation shares (Form 4)

Traded Oct 6 to Oct 8, 2026 · Filed Oct 8, 2026

From Oct 6 to Oct 8, 2026, Rubinstein Julie (President and COO) sold 35,643 Adaptive Biotechnologies Corporation shares at an average US$26.60 for US$948K under a trading plan, leaving 377,802 shares. Filed Oct 8, 2026 (Form 4).

Sold
35,643 shares
Price
US$26.60 average (US$25.66 to US$30.53)
Value
US$948K
Holding after
377,802 shares
Trading plan
Yes (Made under a plan set in advance)
Role
President and COO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Oct 6, 2026Common StockOption exercise11,881US$12.14389,683Direct
Oct 6, 2026Common StockSale9,381US$27.36380,302Direct
Oct 6, 2026Common StockSale1,100US$28.21379,202Direct
Oct 6, 2026Common StockSale901US$29.71378,301Direct
Oct 6, 2026Common StockSale499US$30.53377,802Direct
Oct 7, 2026Common StockOption exercise11,881US$12.14389,683Direct
Oct 7, 2026Common StockSale11,881US$26.40377,802Direct
Oct 8, 2026Common StockOption exercise11,881US$12.14389,683Direct
Oct 8, 2026Common StockSale11,881US$25.66377,802Direct

Source

View original at SEC

Related